U.S. Chargé d’Affaires Trishita Maula highlighted U.S. support for Bangladesh’s efforts to address the ongoing dengue surge, including the provision of 500,000 U.S.-made Dengue NS1 rapid test kits.
During a visit to Kurmitola Multicare Specialized Hospital, Trishita Maula observed firsthand how the test kits are helping strengthen Bangladesh’s capacity to detect and manage dengue, from initial triage and assessment to laboratory diagnosis.
The U.S. support is aimed at improving early detection and strengthening Bangladesh’s capacity to respond to the growing dengue burden.
